Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects

被引:43
作者
Tominaga, Yuji
Mae, Tatsumasa
Kitano, Mitsuaki
Sakamoto, Yoshiro
Ikematsu, Hideyuki
Nakagawa, Kaku
机构
[1] Kaneka Corp, Funct Food Ingredients Div, Kita Ku, Osaka 5308288, Japan
[2] Kaneka Corp, Life Sci RD Ctr, Life Sci Res Labs, Takasago, Hyogo 6768688, Japan
[3] Haradoi Hosp, Higashi Ku, Fukuoka 8138588, Japan
[4] Kamiitabashi Clin, Itabashi Ku, Tokyo 1740076, Japan
关键词
licorice; flavonoid; body fat; body weight; dual-energy X-ray absorptiometry; clinical trial;
D O I
10.1248/jhs.52.672
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Licorice flavonoid oil (LFO) is a new dietary ingredient for functional foods consisting of licorice hydrophobic polyphenols in medium-chain triglycerides (MCT). In an effective dose finding study conducted previously, LFO has exhibited a dose-dependent body fat-reducing effect. Here we report the weight-reducing effect of LFO in a placebo-controlled, double-blind, long-term (12 weeks) ingestion study at 300 mg/day, the minimal effective dose observed in the dose finding study. A total of 103 overweight subjects [body mass index (BMI): 24-30] completed this study and were analyzed. Body weight increased in the placebo group, but was maintained at close to pre-ingestion level in the LFO group, resulting in significant (p < 0.05) differences in the changes in body weight and between the LFO group and the placebo group at each time-point. Dual-energy X-ray absorptiometry (DXA) measurement of body fat indicated that the weight-reducing effect was attributable to reduced body fat. No clinically significant adverse events occurred during the 12-week ingestion period. To confirm the safety of LFO for practical use we also conducted a placebo-controlled, double-blind safety study in 40 overweight subjects with a 4-week excessive ingestion at 1800 mg/day; 6 times the dose of the 300 mg/day study that exhibited a weight-reducing effect. No clinically significant adverse events occurred during the 4-week ingestion period. Based on these findings in both human studies it was shown that LFO is a safe ingredient for functional foods even for long-term or excessive ingestion, with a potential weight-reducing effect.
引用
收藏
页码:672 / 683
页数:12
相关论文
共 32 条
[1]   Clinical applications of body composition measurements using DXA [J].
Albanese, CV ;
Diessel, E ;
Genant, HK .
JOURNAL OF CLINICAL DENSITOMETRY, 2003, 6 (02) :75-85
[2]   Determination of glabridin in human plasma by solid-phase extraction and LC-MS/MS [J].
Aoki, F ;
Nakagawa, K ;
Tanaka, A ;
Matsuzaki, K ;
Arai, N ;
Mae, T .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 828 (1-2) :70-74
[3]   The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation [J].
Belinky, PA ;
Aviram, M ;
Fuhrman, B ;
Rosenblat, M ;
Vaya, J .
ATHEROSCLEROSIS, 1998, 137 (01) :49-61
[4]   Structural aspects of the inhibitory effect of glabridin on LDL oxidation [J].
Belinky, PA ;
Aviram, M ;
Mahmood, S ;
Vaya, J .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (09) :1419-1429
[5]   Comparison of body composition analysis methods in clinical routine [J].
Erselcan, T ;
Candan, F ;
Saruhan, S ;
Ayca, T .
ANNALS OF NUTRITION AND METABOLISM, 2000, 44 (5-6) :243-248
[6]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[7]   Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: Increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure [J].
Fuhrman, B ;
Volkova, N ;
Kaplan, M ;
Presser, D ;
Attias, J ;
Hayek, T ;
Aviram, M .
NUTRITION, 2002, 18 (03) :268-273
[8]   Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: In vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice [J].
Fuhrman, B ;
Buch, S ;
Vaya, J ;
Belinky, PA ;
Coleman, R ;
Hayek, T ;
Aviram, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (02) :267-275
[9]   Antinephritis and radical scavenging activity of prenylflavonoids [J].
Fukai, T ;
Satoh, K ;
Nomura, T ;
Sakagami, H .
FITOTERAPIA, 2003, 74 (7-8) :720-724
[10]   Anti-Helicobacter pylori flavonoids from licorice extract [J].
Fukai, T ;
Marumo, A ;
Kaitou, K ;
Kanda, T ;
Terada, S ;
Nomura, T .
LIFE SCIENCES, 2002, 71 (12) :1449-1463